Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

GSK Investigational Site, Genoa

GSK Investigational Site, Milan

GSK Investigational Site, Neumünster

GSK Investigational Site, Flensburg

GSK Investigational Site, Flensburg

GSK Investigational Site, Flensburg

GSK Investigational Site, Villeneuve Les Avignons

GSK Investigational Site, Herford

GSK Investigational Site, Bad Oeynhausen

GSK Investigational Site, Löhne

GSK Investigational Site, Detmold

GSK Investigational Site, Dax

GSK Investigational Site, Ancenis

GSK Investigational Site, Krefeld

GSK Investigational Site, Essey-lès-Nancy

GSK Investigational Site, Lingolsheim

GSK Investigational Site, Lyon

GSK Investigational Site, Stuttgart

GSK Investigational Site, Schwieberdingen

GSK Investigational Site, Bönnigheim

GSK Investigational Site, Schwäbisch Hall

GSK Investigational Site, Paris

GSK Investigational Site, Le Havre

GSK Investigational Site, Kehl

GSK Investigational Site, Kirchzarten

GSK Investigational Site, Munich

GSK Investigational Site, Olching

GSK Investigational Site, Draguignan

GSK Investigational Site, Kempten (Allgäu)

GSK Investigational Site, Tettnang

GSK Investigational Site, Bad Saulgau

GSK Investigational Site, Boulogne

GSK Investigational Site, Cham

GSK Investigational Site, Bindlach

GSK Investigational Site, Werneck

GSK Investigational Site, Laon

GSK Investigational Site, Nice

GSK Investigational Site, Cagliari

GSK Investigational Site, Sassari